Aquestive Therapeutics
AQST
AQST
57 hedge funds and large institutions have $48.1M invested in Aquestive Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+10
Holders Change %
+21.28%
% of All Funds
0.84%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
17
Reduced
13
Closed
5
Calls
$339K
Puts
$86K
Net Calls
+$253K
Net Calls Change
+$4K
Top Buyers
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$1.71M |
| 2 |
LCM
Legato Capital Management
San Francisco,
California
|
+$688K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$385K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$334K |
| 5 |
Jane Street
New York
|
+$315K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TRCT
51
Tower Research Capital (TRC)
New York
| $8.8K | -$13.2K | -6,517 | -60% |
|
52
Federated Hermes
Pittsburgh,
Pennsylvania
| $4.95K | +$412 | +204 | +9% |
|
53
UBS Group
Zurich,
Switzerland
| $4.63K | +$4.63K | +2,290 | New |
|
|
RWPA
54
Richard W. Paul & Associates
Novi,
Michigan
| $2.88K | – | – | – |
|
|
PA
55
Parallel Advisors
San Francisco,
California
| $202 | +$202 | +100 | New |
|
|
CAS
56
Coppell Advisory Solutions
Coppell,
Texas
| $32 | -$42 | -21 | -57% |
|
57
BNP Paribas Financial Markets
Paris,
France
| $2 | – | – | – |
|
|
GCP
58
GSA Capital Partners
London,
United Kingdom
| – | -$154K | -100,854 | Closed |
|
59
Squarepoint
New York
| – | -$116K | -75,683 | Closed |
|
|
XT
60
XTX Topco
George Town,
Cayman Islands
| – | -$81.1K | -52,980 | Closed |
|
|
HBCM
61
Heron Bay Capital Management
Bloomfield Hills,
Michigan
| – | -$21.5K | -14,025 | Closed |
|
62
Barclays
London,
United Kingdom
| – | -$11K | -7,144 | Closed |
|
63
Man Group
London,
United Kingdom
| – | -$66.7K | – | – |
|